Gyeonggi-do, South Korea

Seunghee Kim

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: C&c Research Laboratories. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seunghee Kim. Retrieved from https://idiyas.com/inventor/seunghee-kim-xwizd14x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seunghee Kim: Innovator in Heterocyclic Derivatives

Introduction

Seunghee Kim is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic derivatives. Her work focuses on compounds that have potential therapeutic applications.

Latest Patents

Seunghee Kim holds a patent for "Heterocyclic derivatives and use thereof." This patent describes a heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof. The compound has an inhibitory effect on the activation of the STAT3 protein, making it useful for the prevention or treatment of diseases associated with the activation of this protein. She has 1 patent to her name.

Career Highlights

Seunghee Kim is currently employed at C&C Research Laboratories, where she continues to innovate and develop new pharmaceutical compounds. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Some of her notable coworkers include Chan Hee Park and Sang Hwi Lee. Their collaborative efforts contribute to the research and development initiatives at C&C Research Laboratories.

Conclusion

Seunghee Kim's contributions to the field of pharmaceuticals through her innovative work on heterocyclic derivatives highlight her role as a key inventor. Her research has the potential to impact the treatment of diseases linked to the STAT3 protein.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…